ReCAP: Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska Over a 1-year period, the mean ...

Evaluation of inducible expression of ERCC1 as a biomarker of drug response in human colorectal cancer cell lines. Background: Although in use for almost 30 years, the clinical value of CEA as the ...

A new research paper was published in Oncotarget's Volume 15 on June 13, 2024, entitled, "Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management ...

Please provide your email address to receive an email when new articles are posted on . Elevated postoperative serum carcinoembryonic antigen increased risk for recurrence, especially within the first ...

The transcription-reverse transcription concerted reaction (TRC) test is a novel molecular-based procedure, which can assess nodal metastasis accurately and quickly. We examined the usefulness of the ...

Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used. If ...

Researchers have identified a blood protein that can be used as a marker of gastric and other cancers and is more accurate than existing diagnostic biomarkers, even in the early stages of the disease.